Michael Detke

2020

In 2020, Michael Detke earned a total compensation of $8.2M as Chief Medical Officer at Cortexyme, a 646% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$164,000
Option Awards$7,630,000
Salary$410,000
Total$8,204,000

Detke received $7.6M in option awards, accounting for 93% of the total pay in 2020.

Detke also received $164K in non-equity incentive plan and $410K in salary.

Rankings

In 2020, Michael Detke's compensation ranked 1,126th out of 13,090 executives tracked by ExecPay. In other words, Detke earned more than 91.4% of executives.

ClassificationRankingPercentile
All
1,126
out of 13,090
91st
Division
Manufacturing
393
out of 5,624
93rd
Major group
Chemicals And Allied Products
135
out of 2,257
94th
Industry group
Drugs
119
out of 1,957
94th
Industry
Biological Products, Except Diagnostic Substances
32
out of 411
92nd
Source: SEC filing on April 29, 2021.

Detke's colleagues

We found four more compensation records of executives who worked with Michael Detke at Cortexyme in 2020.

2020

Casey Lynch

Cortexyme

Chief Executive Officer

2020

Caryn McDowell

Cortexyme

Secretary

2020

Leslie Holsinger

Cortexyme

Executive Vice President of Research and Development

2020

Christopher Lowe

Cortexyme

Chief Financial Officer

News

In-depth

You may also like